|
•
Disorders
•
Health
Professional's Page
•
Parent's Page
• Reports
& Publications
•
Related Links
•
NBS News
•
NBS Privacy Policy
•
NBS Annual Report
•
NBS Studies
•
Statistics
•
Contact NBS
|
NBS Supply Order
Form |
|
 |
|
|
Third Quarter 2011 Program Statistics
|
2011 Statistics (3rd
Quarter – July through September) |
|
|
|
3rd
Quarter |
2011 |
General |
|
22,294 |
64,418 |
Hospital, Birth Center & Home Births* |
|
44,356 |
127,067 |
Specimens Tested (most infants have two newborn screens performed) |
|
3rd
Quarter |
2011 |
Infants Diagnosed |
|
4 |
9a |
Amino Acid disorders |
|
0 |
2 |
Biotinidase Deficiency |
|
6 |
9 |
Congenital Adrenal Hyperplasia |
|
25 |
65 |
Congenital Hypothyroidism |
|
9 |
15 |
Cystic Fibrosis |
|
2 |
2b |
Fatty Acid Oxidation disorders |
|
6 |
9 |
Galactosemia |
|
2 |
3c |
Organic Acid disorders |
|
5 |
12 |
Sickle Cell Disease and Other Clinically Significant Hemoglobinopathies |
|
59 |
126 |
All Dried Blood
Tests Combined |
|
11 |
46 |
Early Hearing Loss |
|
70 |
172 |
All Disorders Combined |
|
* Excludes babies born at Bremerton and Whidbey Island Naval hospitals |
|
a Six infants with phenylketonuria (PKU), one with maple syrup urine disease (MSUD), one with tyrosinemia type 1 (TYR-1), and one with citrullinemia |
|
b Both infants with medium chain acyl-CoA dehydrogenase(MCAD) deficiency |
|
c
One infant with propionic acidemia (PROP),
and a set of twins both with methylmalonic acidemia (MMA MUT). Excludes
seven children with conditions not on the screening panel: three with
methylmalonic acidemia cobalamin C (MMA CblC) deficiency, two with
2-methylbutyryl-CoA dehydrogenase (2-MBD) deficiency, one with
3-methylcrotonyl-CoA carboxylase (3-MCC) deficiency, and one with
3-methylglutaconic aciduria (3-MGA) |
Maternal Steroids: Why Are We Asking?
 If you’ve received the newest version of our newborn screening collection card, you’ve probably been wondering why we’ve added a field inquiring about maternal steroids. The reason is that steroids can produce a false negative screening result for a baby with congenital adrenal hyperplasia (CAH). We originally thought that only steroids administered to the baby would affect results. However, some endocrinologists believe that steroids, in any form (oral, nasal or even topical), could be transferred to the unborn baby through the mother if they are used within seven days prior to delivery. Also, if the mother is nursing, steroids can be passed through the breast milk to the baby if the mother continues to use steroids after delivery.
 Bottom line:
For babies exposed to steroids, a subsequent specimen should be collected 7-10 days after discontinuing therapy to reduce the chance of missing an affected child. If the mother continually uses steroids, and breast feeds, negative screening results will not be reliable to rule out CAH.
Our Customer Service Surveys
 Thank you to those who completed our survey last quarter on the value of our hospital compliance reports. Based on comments received, we’ve made some changes that we hope will be helpful.
We’ve included another survey this quarter to find out how we are doing regarding basic aspects of our customer service. This area is of particular importance to us as we know that prompt and courteous service is critical to fostering effective partnerships with our stakeholders.
Newborn Screening LISTSERV
If
you haven’t signed up yet, please join our LISTSERV. It is a resource
available to health care providers to distribute information, increase
program efficiency, and improve the quality of newborn screening
services. To join our mailing list, please visit the Newborn Screening
LISTSERV subscription webpage:
http://tinyurl.com/NBSLIST
|
